Last updated on September 2018

Study of Efficacy and Safety of Bimagrumab in Patients After Hip Fracture Surgery

Brief description of study

The purpose of this study is to assess if bimagrumab is safe and effective in patients with muscle wasting (atrophy) after hip fracture surgery.

Clinical Study Identifier: NCT02152761

Contact Investigators or Research Sites near you

Start Over

Novartis Pharmaceuticals

Novartis Investigative Site
Barranquilla, Colombia